We report a patient with massive facial sarcoidosis. While skin involvement is a common manifestation of sarcoidosis, it is unusual to see it in the dramatic form of cutaneous tumors with mutilation of the central face. There are few reports of tumoral cutaneous sarcoidosis like that of our patient.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000018262 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Background: There is limited knowledge of the long-term effects on the immune system after treatment for diffuse large B-cell lymphoma (DLBCL).
Methods: This study included DLBCL patients from the Danish Lymphoma Registry who obtained complete remission (CR) after (R)-CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone)-like immunochemotherapy. Each R CHOP-like treated patient was matched to five comparators from the Danish background population and furthermore compared to R CHOP-like treated patients.
Generalized sarcoidosis associated with hypertrophic osteopathy in a Standardbred racehorse.
J Equine Vet Sci
January 2025
Department of Functional Sciences, Equine Division, Sports Medicine Section, Faculty of Veterinary Medicine, University of Liège, Liège, Belgium. Electronic address:
Article Synopsis
- A Standardbred racehorse presented with exercise intolerance, weight loss, fever, and facial deformity, leading to diagnostic imaging revealing soft tissue swelling and periostitis.
- Radiological findings indicated bilateral periostitis in limbs, alongside skin lesions diagnosed as granulomatous dermatitis, suggesting equine sarcoidosis.
- The horse was euthanized after a rapid health decline, with post-mortem findings confirming generalized equine sarcoidosis and the detection of equine herpesvirus 5 DNA.
Elevated Mortality Risk in the First Year Post-Diagnosis of Sarcoidosis: A Comprehensive Population-Based Cohort Study.
Medicina (Kaunas)
November 2024
Department of Internal Medicine B, Sheba Medical Center, Tel-Hashomer, Ramat Gan 52621, Israel.
Article Synopsis
- Sarcoidosis is a condition that causes chronic inflammation and the formation of granulomas, which can lead to varying outcomes; some patients have mild issues while others face severe complications and higher mortality risk.
- A retrospective cohort study analyzed data from Clalit Health Services to compare mortality rates between sarcoidosis patients and matched controls, revealing a significantly higher mortality rate (17.7% vs. 10.6%).
- The study found that younger patients (under 50) experienced the highest mortality risk shortly after diagnosis, with age, male gender, and higher comorbidity scores being key predictors of increased mortality.
Ear, Nose, and Throat sarcoidosis: An etiology that should raise a flag? About two case reports.
Tunis Med
November 2024
Department of Internal Medicine, Rabta University Hospital Center, Tunisia.
Introduction: Sarcoidosis is a chronic inflammatory disease characterized by non-caseous necrotizing epithelial cell granulomas that can affect any organ. Ear, nose, and throat (ENT) involvement is rare. We report two cases of systemic sarcoidosis with ENT onset.
View Article and Find Full Text PDFDiagnostic and Therapeutic Insights Into Pediatric Neurosarcoidosis: Observations From French Pediatric Rheumatology Centers.
Pediatr Neurol
January 2025
Department of General Pediatrics, Pediatric Internal Medicine, Rheumatology and Infectious Diseases, National Reference Centre for Rare Pediatric Inflammatory Rheumatisms and Systemic Autoimmune Diseases (RAISE), Robert-Debré University Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; Université Paris Cité, INSERM, Centre de Recherche sur l'inflammation UMR 1149, Paris, France. Electronic address:
Article Synopsis
- - The study reviewed 11 pediatric patients diagnosed with neurosarcoidosis (NS), predominantly affecting girls, with an average diagnosis age of around 10 to 11.5 years, highlighting typical neurological symptoms such as headaches and eye involvement.
- - Most patients experienced meningitis and were treated primarily with corticosteroids and TNF-alpha inhibitors, with eight out of 11 requiring biologic therapies to achieve remission.
- - The findings emphasize the importance of recognizing the clinical features of pediatric NS and suggest that early intervention with TNF-alpha biologics can lead to better management outcomes for these children.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!